LinkGevity recognized for pioneering Anti-Necrotic™ technology
The article from The Observer spotlights LinkGevity’s Anti-Necrotic™ platform for its potential to prevent cell death, strengthen resilience, and promote longevity
A destructive form of cell death might be the key to slowing the human aging process
Experts across scientific and clinical fields, writing in Nature Oncogene, explore the emerging role of necrosis in aging—pointing to its potential to reshape how we understand and treat age-related conditions.
LinkGevity awarded Innovate UK Smart Grant for Anti-Necrotic™ research to prevent kidney deterioration
The Smart Grant will be used in a one-year project involving the company’s Anti-Necrotic™ technology, specifically around acute tubular necrosis (ATN), which is a leading cause of kidney dysfunction, degeneration and ageing.
Science Communication
Stay informed about the latest seminars, talks, and other public communications of our groundbreaking research and discoveries.
